Home » Newsletters » BioWorld Science

BioWorld Science

March 10, 2010

View Archived Issues

New Pim kinase inhibitor ARRY-770 reduces airway hyperresponsiveness in mice

Adalimumab improves quality of life in Crohn's disease patients

Evotec Neurosciences claims bradykinin B1 receptor antagonists

CETP gene polymorphism linked to reduced risk for dementia

Topical WBI-1001 improves atopic dermatitis in double-blind trial

Roche discovers new GlyT-1 inhibitors

Merck KGaA discloses novel tyrosine kinase inhibitors

Bayer Schering claims new adenosine A1 receptor antagonists

Sanofi-aventis patents new cannabinoid CB1 receptor antagonists

NIAID awards PDS phase II grant for HPV cancer vaccine

Ark withdraws Cerepro MAA after EMA's request for further trial in malignant glioma

Vernalis terminates agreement with PCH and regains rights to frovatriptan

Biotie and Pfizer to end discovery phase of development of PDE10 inhibitors for schizophrenia

Stanford University requests data from Favrille's cancer vaccine trials

Ischemix begins phase IIa CMX-2043 trial in ischemia reperfusion injury

Ista receives action date for FDA review of XiDay sNDA

Chimerix begins phase II CMX-001 study in CMV-seropositive stem cell transplant recipients

Bristol-Myers and AstraZeneca begin phase IV Onglyza trial

Enrollment begins in phase IIb trial of NTx-265 in acute ischemic stroke

mtm laboratories launches cervical cancer test CINtec Plus in Europe

Omthera to advance Epanova for hypertriglyceridemia

Celltrion develops broad-spectrum human monoclonal antibodies against influenza

Omeros licenses Asubio's PDE7 inhibitors for movement disorders

Harvard and Dana-Farber grant Acetylon exclusive license to HDAC inhibitor discovery platform

Abbott and GSK to develop molecular diagnostic test for skin cancer treatment

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...